Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
CGEN
COMPUGEN LTD
NASDAQ · Biological Products, (No Diagnostic Substances)
Last close
$2.38
· 2026-09-30
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
Biological Products, (No Diagnostic Substances)
RECENT INSIDER TRADES
2026-07-13
· Levine Zurit
(SVP, Business Development)
· SELL
2026-07-13
· Levine Zurit
(SVP, Business Development)
· OTHER
2026-04-27
· Levine Zurit
(SVP, Business Development)
· SELL
2026-04-27
· Ophir Eran
(President and CEO)
· SELL
2026-04-27
· Ophir Eran
(President and CEO)
· OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders
87
Shares held
14,590,065
Value
$30.91M
Percent of shares outstanding
15.43%
As of quarter end
2026-06-30
RECENT NEWS
Stifel reiterates Compugen stock rating on ovarian trial update
Compugen to participate in H.C. Wainwright AI drug discovery conference
Compugen Ltd. (CGEN) Discusses COM701 in Ovarian Cancer, MAIA Trial Preview, and UNIGEN Platform Advancements Transcript
Compugen to host virtual KOL event on COM701 and Unigen platform on October 5
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS